Affiliation:
1. Gujarat Technological University, Ahmedabad, Gujarat 382424, India
2. Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat 388001, India
Abstract
Objective:
To investigate the cardioprotective potential of betulin in isoproterenol (ISO)-induced myocardial injury in rats.
Methods:
Wistar rats were divided into five groups (n=10): normal, ISO, nebivolol 5 mg/kg, and betulin (20 & 40 mg/kg). Nebivolol and betulin were administered orally for 29 days. ISO (85 mg/kg) was administered subcutaneously on day 27 and day 28 to induce myocardial injury. On day 29, blood was collected for determination of cardiac markers, and hemodynamic parameters were investigated. The levels of oxidative stress markers and the gene expressions of apoptotic markers and inflammatory mediators were evaluated. Moreover, 2,3,5-triphenyltetrazolium chloride staining and histopathological analysis were also performed.
Results:
Betulin reduced the size of myocardial infarction, decreased elevated levels of cardiac enzymes, and maintained hemodynamic functions. It also inhibited ISO-induced upregulation of Bax, caspase-3, NF-κB, and 1L-6, enhanced endogenous antioxidant enzymes, and reduced lipid peroxidation. Additionally, pretreatment with betulin alleviated myocardial ischemic damage, as reflected by reduced myonecrosis, edema, and inflammatory changes.
Conclusions:
Betulin exhibits strong cardioprotective activity against ISO-induced myocardial injury by anti-inflammatory, anti-apoptotic, and antioxidant activities.
Reference33 articles.
1. Cardiovascular disease (CVD) and its associated risk factors among older adults in India: Evidence from LASI Wave 1;Kundu;Clin Epidemiol Glob Health,2021
2. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study;Roth;J Am Coll Cardiol,2020
3. Current status and limitations of myocardial infarction large animal models in cardiovascular translational research;Shin;Front Bioeng Biotechnol,2021
4. New strategies to enhance myocardial regeneration: Expectations and challenges from preclinical evidence;Rurali;Curr Stem Cell Res Ther,2020
5. Advancements in myocardial infarction management: Exploring novel approaches and strategies;Sachdeva;Cureus,2023